Search Results for "Gen9 Funding"
Original Source: Gen9, Inc.
Gen9 is building on advances in synthetic biology to power a scalable fabrication capability that will significantly increase the worldâs capacity to produce DNA content. The privately held companyâs next-generation gene synthesis technology allows for the high-throughput, automated production of DNA constructs at lower cost and higher accuracy than previous methods on the market. Founded by world leaders in synthetic biology, Gen9 aims to ensure th...
Matching Channels
Colorado is a state in the south-west of the US, in the Southern Rocky Mountains. It is home to a fast growing and exciting biotechnology industry. The Colorado BioScience Association founded in 200...
Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...
In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over...
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...
Maryland, the US state on the mid-Atlantic coast, is hub of biotechnology institutions and companies. In 2005/2006 is was the 2nd best area globally for initiatives aimed at drawing and retaining bi...
Matching News
Gen9 Announces Winners of Synthetic DNA Contest
Bio-IT World | Gen9, a developer of scalable technologies for synthesizing and assembling DNA, today announced the five winners of its inaugural G-Prize contest. Collectively, the awardees stand to r...
Gen9 raises $21 million from Agilent
Synthetic biology company Gen9 Inc. (Cambridge, Mass.) raised $21 million in a series C round from tool company Agilent Technologies Inc. (NYSE:A). Gen9's BioFab platform comprises gene synthesis tech...
Gen9, Synthetic Biology Startup, Snags $21M from Agilent
Scientists have been able to order up custom-synthesized genes on demand for quite a few years now. But if synthetic biology is going to move beyond small lab experiments and disrupt whole industries...
Stealthy Gen9 Rolls Out BioFab for Large-Scale Gene Manufacturing
For the past three years, Cambridge, MA-based Gen9 has been quietly building something that its founders believe has been sorely lacking in biotech: an affordable and efficient way to synthesize genes...
Matching PubMed Articles
Funding for teratology information services: Up, down, and all around.
Funding for Teratology Information Services has been an ongoing struggle over the 25 years of its existence. Traditional and novel funding mechanisms have been explored with varying success. The impor...
Over the past 20 years, states have increasingly moved away from centrally financed, state-operated facilities to financing models built around community-based service delivery mechanisms. This paper...
Funding in 2011: East heats up as west cools down.
The great slowdown in the global economy since 2008 is putting the brakes on government spending for health research funding worldwide. Could this be an opportunity for research centers in Asia to shi...
How physicians interpret research funding disclosures.
To the Editor: Kesselheim et al. (Sept. 20 issue)(1) report on the likelihood that data obtained from hypothetical clinical trials, stratified by rigor of design and source of funding, will be adopted...
How physicians interpret research funding disclosures.
To the Editor: Kesselheim et al. (Sept. 20 issue)(1) report on the likelihood that data obtained from hypothetical clinical trials, stratified by rigor of design and source of funding, will be adopted...
